Enteric to receive £800,000 funding for gastrointestinal disease research
The Gastrointestinal Disease Healthcare Technology Cooperative (Enteric), based at the National Centre for Bowel Research and Surgical Innovation (NCBRSI) at Queen Mary, University of London's Whitechapel campus, is pleased to announce that it will receive funding of £800,000 over four years from the National Institute for Health Research (NIHR).
In 2008, Enteric was chosen by the NIHR as one of two pilot Healthcare Technology Cooperatives (HTC), created to provide a national focus for technology development with the NHS within a specific clinical area of unmet need. The success of the pilot project has led to the creation of eight further HTCs, including Enteric, sharing funding of £6.4m over four years.
Enteric has worked to identify and develop new devices and procedures to improve the lives of people with Crohn's disease, ulcerative colitis, bowel cancer and other disorders affecting the way the bowels work. Innovations include new surgical procedures and instrumentation for bowel surgery.
In 2011 they received the prestigious Cutlers' Surgical Award for the development of a new surgical stapler. The HTC is led jointly by Professor Norman Williams, President of The Royal College of Surgeons and Honorary Professor at Barts and The London School of Medicine and Dentistry, and Charles Knowles, Clinical Professor of Surgical Research.
Enteric works with Barts Health NHS Trust and groups in Birmingham, Bristol, Durham, Edinburgh, Hull, Oxford, Manchester, Newcastle and Nottingham with the aim of providing a national resource for innovation and health improvement in bowel disorders and chronic gastrointestinal disease - an often neglected clinical area. The HTC seeks innovative ways to bring together patients, carers, clinicians, scientists and industry to develop new technologies, treatments and devices in this field.
Please contact enteric at email@example.com if:
- You have a need that is not currently met by existing devices or practices
- You have identified a new or expanded use for an existing technology
- You have an idea that promises to improve treatments or management
- You have a device or diagnostic system in development.
For media information, contact: